These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 2828663)
1. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat. Hauber J; Cullen BR J Virol; 1988 Mar; 62(3):673-9. PubMed ID: 2828663 [TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. Garcia JA; Harrich D; Soultanakis E; Wu F; Mitsuyasu R; Gaynor RB EMBO J; 1989 Mar; 8(3):765-78. PubMed ID: 2721501 [TBL] [Abstract][Full Text] [Related]
3. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Kamine J; Subramanian T; Chinnadurai G Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310 [TBL] [Abstract][Full Text] [Related]
4. Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation. Hess JL; Small JA; Clements JE J Virol; 1989 Jul; 63(7):3001-15. PubMed ID: 2542608 [TBL] [Abstract][Full Text] [Related]
5. Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bel1 protein requires a specific DNA sequence. Lee AH; Lee KJ; Kim S; Sung YC J Virol; 1992 May; 66(5):3236-40. PubMed ID: 1313928 [TBL] [Abstract][Full Text] [Related]
6. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. Brady J; Jeang KT; Duvall J; Khoury G J Virol; 1987 Jul; 61(7):2175-81. PubMed ID: 3035218 [TBL] [Abstract][Full Text] [Related]
7. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages. Murphy KM; Sweet MJ; Ross IL; Hume DA J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418 [TBL] [Abstract][Full Text] [Related]
8. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547 [TBL] [Abstract][Full Text] [Related]
9. The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function. Venkatesh LK; Chinnadurai G J Virol; 1993 Jul; 67(7):3868-76. PubMed ID: 8389909 [TBL] [Abstract][Full Text] [Related]
10. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100 [TBL] [Abstract][Full Text] [Related]
11. Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression. Rosen CA; Park R; Sodroski JG; Haseltine WA Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4919-23. PubMed ID: 3037527 [TBL] [Abstract][Full Text] [Related]
12. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Selby MJ; Bain ES; Luciw PA; Peterlin BM Genes Dev; 1989 Apr; 3(4):547-58. PubMed ID: 2470647 [TBL] [Abstract][Full Text] [Related]
13. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193 [TBL] [Abstract][Full Text] [Related]
14. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Kao SY; Calman AF; Luciw PA; Peterlin BM Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027 [TBL] [Abstract][Full Text] [Related]
15. The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression. Kim YS; Panganiban AT J Virol; 1993 Jul; 67(7):3739-47. PubMed ID: 8510203 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279 [TBL] [Abstract][Full Text] [Related]
17. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2. Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420 [TBL] [Abstract][Full Text] [Related]
18. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. Lisziewicz J; Rappaport J; Dhar R New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768 [TBL] [Abstract][Full Text] [Related]
19. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036 [TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat. Bohan CA; Robinson RA; Luciw PA; Srinivasan A Virology; 1989 Oct; 172(2):573-83. PubMed ID: 2800338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]